HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel mutation in ornithine transcarbamylase gene causing mild intermittent hyperammonemia.

Abstract
We report a 3-year-old Saudi boy with recurrent episodes of vomiting, poor feeding, and altered mental status accompanied by an intermittent mild hyperammonemia, and a large elevation of urinary orotic acid. Sanger sequencing of the ornithine transcarbamylase (OTC) gene revealed a novel hemizygous deletion at the fourth nucleotide of intron 4 (c.386+4delT) in the proband and his asymptomatic mother. This novel mutation in the OTC gene is responsible for the late-onset phenotype of OTC deficiency.
AuthorsSarar Mohamed, Muddathir H Hamad, Altaf A Kondkar, Khaled K Abu-Amero
JournalSaudi medical journal (Saudi Med J) Vol. 36 Issue 10 Pg. 1229-32 (Oct 2015) ISSN: 0379-5284 [Print] Saudi Arabia
PMID26446336 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ornithine Carbamoyltransferase
Topics
  • Base Sequence
  • Child, Preschool
  • Hemizygote
  • Humans
  • Hyperammonemia (diagnosis, etiology, genetics)
  • Male
  • Ornithine Carbamoyltransferase (genetics)
  • Ornithine Carbamoyltransferase Deficiency Disease (diagnosis, genetics)
  • Sequence Deletion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: